BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 823087)

  • 21. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
    Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
    Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
    Henry P
    Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
    [No Abstract]   [Full Text] [Related]  

  • 23. [A study of 93 cases of painful shoulder and shoulder-band syndrome treated with hydergine (author's transl)].
    Yaya Huamán R; Blasco Olcina R; García Fernández M; Vilches Padilla JJ
    Rev Esp Otoneurooftalmol Neurocir; 1975; 33(193):131-5. PubMed ID: 56021
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of chronic arterial occlusive disease of the lower limbs with propionyl-1-carnitine in elderly patients].
    Terranova R; Luca S
    Minerva Med; 2001 Feb; 92(1):61-6. PubMed ID: 11317141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
    Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C; Pollari G; Carioti B; Sardina M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy of peripheral arterial occlusive disease].
    Mahler F
    Schweiz Med Wochenschr; 1981 May; 111(18):637-40. PubMed ID: 7244587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
    Bauer U
    Arzneimittelforschung; 1984; 34(6):716-20. PubMed ID: 6386008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
    Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of raubasine in long-term therapy of obliterating arteriopathies].
    Andreozzi GM; Signorelli S; Magnano V; Savoca N; Mazzerbo A; Cottini E; Sorrentino F
    Minerva Cardioangiol; 1979; 27(1-2):61-6. PubMed ID: 471237
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
    Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
    Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous PGE-1 in peripheral vascular obstructive disease: use over a 6-month period].
    Llorente Gutiérrez J; González Fernández MA; Fuentes Irigoyen R; Jiménez Caballero E
    Farm Hosp; 2004; 28(3):188-91. PubMed ID: 15222872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
    Royer RJ
    Minerva Med; 1976 May; 67(25):1656-61. PubMed ID: 778667
    [No Abstract]   [Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients.
    Gardner AW; Killewich LA
    Vasc Med; 2001; 6(1):9-14. PubMed ID: 11358164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.